Figure 3.

Neuroblastoma PDXs retain patient tumour-specific chromosomal aberrations. Arrows indicate neuroblastoma-typical regions; such as 1p deletion, MYCN amplification, 9p deletion and 17q gain for patient tumours and their corresponding PDXs.

Neuroblastoma PDXs retain patient tumour-specific chromosomal aberrations. Arrows indicate neuroblastoma-typical regions; such as 1p deletion, MYCN amplification, 9p deletion and 17q gain for patient tumours and their corresponding PDXs.